APP and Alzheimer disease: The current knowledge about γ-secretase, its C99 substrate, and its Aβ products is integrated in one coherent molecular mechanism in an attempt to describe pathogenesis of Alzheimer's disease and to propose novel strategies for development of the drug candidates.